BUZZ-3SBio drops most in seven months on unit spin-off plans

Reuters11-21

** Shares of biopharmaceutical product producer 3SBio Inc 1530.HK drop 8.9% to HK$29.52, their biggest intraday pct decline since April 28

** Stock touches the lowest point since November 12, and set to snap two consecutive sessions of gains, if losses hold

** 3SBio proposes to spin off and separately list the shares of its 87.16%-owned skin health and weight management solution unit Mandi Inc on the main board of the Hong Kong stock exchange

** The Stock Exchange has confirmed that the company may proceed with the proposed spin-off plans, and will not retain any interest in the specialized consumer pharmaceuticals unit Mandi on completion of the listing

** YTD, stock up 400%, Hang Seng Biotech Index .HSBIO up 77%

(Reporting by Donny Kwok)

((donny.kwok@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2585191925?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-21 14:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2585191925","market":"us","top_or_hot":-1,"title":"BUZZ-3SBio drops most in seven months on unit spin-off plans","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-3SBio drops most in seven months on unit spin-off plans</title></head><body><p>** Shares of biopharmaceutical product producer <a href=\"https://laohu8.com/S/TRSBF\">3SBio Inc</a> <span>1530.HK</span> drop 8.9% to HK$29.52, their biggest intraday pct decline since April 28</p><p>** Stock touches the lowest point since November 12, and set to snap two consecutive sessions of gains, if losses hold </p><p>** 3SBio proposes to spin off and separately list the shares of its 87.16%-owned skin health and weight management solution unit <span>Mandi Inc</span> on the main board of the Hong Kong stock exchange</p><p>** The Stock Exchange has confirmed that the company may proceed with the proposed spin-off plans, and will not retain any interest in the specialized consumer pharmaceuticals unit Mandi on completion of the listing </p><p>** YTD, stock up 400%, <a href=\"https://laohu8.com/S/HSNGF\">Hang Seng</a> Biotech Index <span>.HSBIO</span> up 77%</p><p> (Reporting by Donny Kwok)</p><p> ((donny.kwok@thomsonreuters.com))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-3SBio drops most in seven months on unit spin-off plans</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-3SBio drops most in seven months on unit spin-off plans\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-11-21 14:15</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-3SBio drops most in seven months on unit spin-off plans</title></head><body><p>** Shares of biopharmaceutical product producer <a href=\"https://laohu8.com/S/TRSBF\">3SBio Inc</a> <span>1530.HK</span> drop 8.9% to HK$29.52, their biggest intraday pct decline since April 28</p><p>** Stock touches the lowest point since November 12, and set to snap two consecutive sessions of gains, if losses hold </p><p>** 3SBio proposes to spin off and separately list the shares of its 87.16%-owned skin health and weight management solution unit <span>Mandi Inc</span> on the main board of the Hong Kong stock exchange</p><p>** The Stock Exchange has confirmed that the company may proceed with the proposed spin-off plans, and will not retain any interest in the specialized consumer pharmaceuticals unit Mandi on completion of the listing </p><p>** YTD, stock up 400%, <a href=\"https://laohu8.com/S/HSNGF\">Hang Seng</a> Biotech Index <span>.HSBIO</span> up 77%</p><p> (Reporting by Donny Kwok)</p><p> ((donny.kwok@thomsonreuters.com))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HK0000165453.HKD","symbol_name":"华夏精选大中华科技基金 A类港币","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251121:nL1N3WX06I:1","article_id":"2585191925","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2585191925","pubTimestamp":1763705740,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-3SBio drops most in seven months on unit spin-off plans** Shares of biopharmaceutical product producer 3SBio Inc 1530.HK drop 8.9% to HK$29.52, their biggest intraday pct decline since April 28** Stock touches the lowest point since November 12, and set to snap two consecutive sessions of gains, if losses hold ** 3SBio proposes to spin off and separately list the shares of its 87.16%-owned skin health and weight management solution unit Mandi Inc on the main board of the Hong Kong stock exchange** The Stock Exchange has confirmed that the company may proceed with the proposed spin-off plans, and will not retain any interest in the specialized consumer pharmaceuticals unit Mandi on completion of the listing ** YTD, stock up 400%, Hang Seng Biotech Index .HSBIO up 77%  ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HK0000165453.HKD":"华夏精选大中华科技基金 A类港币","01530":"三生制药","BK1583":"高瓴概念","BK1161":"生物科技","BK1593":"医美概念股"},"translate_title":"BUZZ-3SBio因部门分拆计划股价创七个月来最大跌幅","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01530":0.9},"content_text":"BUZZ-3SBio drops most in seven months on unit spin-off plans** Shares of biopharmaceutical product producer 3SBio Inc 1530.HK drop 8.9% to HK$29.52, their biggest intraday pct decline since April 28** Stock touches the lowest point since November 12, and set to snap two consecutive sessions of gains, if losses hold ** 3SBio proposes to spin off and separately list the shares of its 87.16%-owned skin health and weight management solution unit Mandi Inc on the main board of the Hong Kong stock exchange** The Stock Exchange has confirmed that the company may proceed with the proposed spin-off plans, and will not retain any interest in the specialized consumer pharmaceuticals unit Mandi on completion of the listing ** YTD, stock up 400%, Hang Seng Biotech Index .HSBIO up 77% (Reporting by Donny Kwok) ((donny.kwok@thomsonreuters.com))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding,event","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.10","shortVersion":"4.35.10","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2585191925","isCrawlerRequest":true}